First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset

Satouchi, M; Nosaki, K; Takahashi, T; Nakagawa, K; Aoe, K; Kurata, T; Sekine, A; Horiike, A; Fukuhara, T; Sugawara, S; Umemura, S; Saka, H; Okamoto, I; Yamamoto, N; Sakai, H; Kishi, K; Katakami, N; Horinouchi, H; Hida, T; Okamoto, H; Atagi, S; Ohira, T; Han, SR; Noguchi, K; Ebiana, V; Hotta, K

Hotta, K (corresponding author), Okayama Univ Hosp, Ctr Innovat Clin Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.

CANCER SCIENCE, 2020; 111 (12): 4480

Abstract

This prespecified subanalysis of the global, randomized controlled phase III KEYNOTE-024 study of pembrolizumab vs chemotherapy in previously untreate......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索